JP2018507854A5 - - Google Patents

Download PDF

Info

Publication number
JP2018507854A5
JP2018507854A5 JP2017542389A JP2017542389A JP2018507854A5 JP 2018507854 A5 JP2018507854 A5 JP 2018507854A5 JP 2017542389 A JP2017542389 A JP 2017542389A JP 2017542389 A JP2017542389 A JP 2017542389A JP 2018507854 A5 JP2018507854 A5 JP 2018507854A5
Authority
JP
Japan
Prior art keywords
seq
mutant
motif
amino acid
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017542389A
Other languages
English (en)
Japanese (ja)
Other versions
JP6896636B2 (ja
JP2018507854A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2016/073773 external-priority patent/WO2016127948A1/zh
Publication of JP2018507854A publication Critical patent/JP2018507854A/ja
Publication of JP2018507854A5 publication Critical patent/JP2018507854A5/ja
Application granted granted Critical
Publication of JP6896636B2 publication Critical patent/JP6896636B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017542389A 2015-02-13 2016-02-14 組換えタンパク質薬の分子設計 Active JP6896636B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201510079486 2015-02-13
CN201510079486.7 2015-02-13
CN201510736184 2015-11-02
CN201510736184.2 2015-11-02
PCT/CN2016/073773 WO2016127948A1 (zh) 2015-02-13 2016-02-14 一种重组蛋白质药物的分子设计

Publications (3)

Publication Number Publication Date
JP2018507854A JP2018507854A (ja) 2018-03-22
JP2018507854A5 true JP2018507854A5 (https=) 2019-03-14
JP6896636B2 JP6896636B2 (ja) 2021-06-30

Family

ID=56614147

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017542389A Active JP6896636B2 (ja) 2015-02-13 2016-02-14 組換えタンパク質薬の分子設計

Country Status (7)

Country Link
US (2) US10869910B2 (https=)
EP (1) EP3269731B1 (https=)
JP (1) JP6896636B2 (https=)
CN (2) CN107428809B (https=)
AU (2) AU2016218635B2 (https=)
DK (1) DK3269731T5 (https=)
WO (1) WO2016127948A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101890155B (zh) * 2010-05-25 2012-07-25 江苏先声药物研究有限公司 一种药物组合物及其应用
JP6336389B2 (ja) * 2011-09-09 2018-06-06 チンファ ユニヴァーシティTsinghua University Atp結合部位に変異を有するエンドスタチン変異体
US20180015148A1 (en) * 2014-11-03 2018-01-18 Tsinghua University Drug for inhibiting adipose cell differentiation and insulin resistance

Similar Documents

Publication Publication Date Title
JP7166933B2 (ja) プログラム細胞死を誘導するcd47のアゴニスト剤及びプログラム細胞死の欠陥と関連する疾患の治療におけるそれらの使用
CA2387184C (en) Cell-permeable peptide inhibitors of the jnk signal transduction pathway
JP5734865B2 (ja) 選択性に優れた抗がんキメラペプチド
JP5559087B2 (ja) 胃腸障害の治療のための方法および組成物
JP2008501310A6 (ja) 胃腸障害の治療のための方法および組成物
JP2016540739A (ja) 神経保護ペプチド
US11041157B2 (en) Slit2D2-HSA fusion protein and use thereof against tumours
EP2688582A1 (en) Neuroprotective peptides
JP2026041880A (ja) 細胞透過性ペプチド変異体およびその用途
JP4902919B2 (ja) ペプチド作成の方法
JP6953579B2 (ja) 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用
JP6903633B2 (ja) 腫瘍抑制ペプチド
JP2013535965A5 (https=)
CN100549175C (zh) 一种具有抑癌作用的重组蛋白及其编码基因与应用
WO2015055148A1 (zh) Yap蛋白抑制多肽及其应用
JP2018507854A5 (https=)
WO2008120263A2 (en) Prokineticins receptors antagonists, derivatives and uses thereof
KR100641535B1 (ko) 브이이지에프 펩티드 및 그 용도
JPH04182497A (ja) ポリペプチド
KR20220137876A (ko) 조직 재생의 촉진에 유용한 hmgb1과 관련된 폴리펩티드, 이를 포함하는 조성물, 및 이들의 용도
WO2015135925A1 (en) Respiratory syncytial virus (rsv) replication inhibitors
CN106589064A (zh) 高活性的肿瘤抑制剂及其制法和应用
CN111094357B (zh) 一类新的Bcl10聚合抑制剂及其应用
CN102378765A (zh) 拮抗糖胺聚糖的mcp-1突变体及其用途
JP6896636B2 (ja) 組換えタンパク質薬の分子設計